Total funding allocated to projects this organisation participated or coordinated
Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.
Total number of projects: 5
As coordinator: 0
As participant: 5
Sole participant: 0
Coordinator / Participant Ratio: 0*
*Ratio includes only projects with > 2 partners
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2020 | 0 | 19.887.642 | 360.000 | 1 | ||
2016 | 0 | 8.553.750 | 701.250 | 1 | ||
2013 | 0 | 5.999.983 | 994.800 | 1 | ||
2010 | 0 | 14.099.975 | 499.025 | 2 |
Total number of partners:77
Partner loyalty:
Frequent Partner: (> 2 projects): 6
Rare Partner: 71
Frequent / Rare Partner Ratio: 0.08
Subject: | No: |
---|---|
LIFE SCIENCES | 2 |
HEALTH | 2 |
MEDICINE, HEALTH | 2 |
MEDICINE | 2 |
MEDICAL BIOTECHNOLOGY | 1 |
Category: | No: |
---|---|
BIOLOGICAL SCIENCES | 3 |
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2020-12-01 | Connecting European Cohorts to Increase Common and Effective Response to SARS-CoV-2 Pandemic: ORCHESTRA | ORCHESTRA | participant | 19.887.642 | 26 |
2016-04-01 | SYSTEMS ANALYSIS OF ADULT AND PEDIATRIC RESPONSES TO THE VSV-ZEBOV EBOLA VACCINE - Sofia ref.: 116068 | VSV-EBOPLUS | participant | 8.553.750 | 11 |
2013-10-01 | "Developing and Testing a novel, low-cost, effective HOOKworm VACcine to Control Human Hookworm Infection in endemic countries" | HOOKVAC | participant | 5.999.983 | 9 |
2010-03-01 | Dissecting the Immunological Interplay between Poverty Related Diseases and Helminth Infections: An African-European Research Initiative | IDEA | participant | 10.300.000 | 23 |
2010-02-01 | The targeted development of a new generation Vaccine for Schistosomiasis | TheSchistoVac | participant | 3.799.975 | 13 |